Oregon Health and Science University (OHSU)

Postdoctoral Opportunities in Tumor Microenvironment/Immunology

Oregon Health & Science University (OHSU)

Portland, OR, United States

Postdoctoral Opportunities in Tumor Microenvironment/Immunology at Oregon Health & Science University

Laboratories within the Knight Cancer Institute at Oregon Health & Science University in beautiful Portland, OR have multiple openings for postdoctoral fellows.

Visit http://www.ohsu.edu/cdcb-postdoc for links to laboratories with openings. Please apply directly to laboratory principal investigators via email.

Sud Anand, PhD: Research projects on non-coding RNAs in host cells impacting solid tumor progression with emphasis on immune cells in the tumor microenvironment.

Lisa M Coussens, PhD: We are broadly interested in understanding signals controlling innate and adaptive leukocyte responses and activities in solid tumors with projects examining myeloid – T cell cross talk and mechanisms regulated by complement proteins as mediators of tumor progression and tumor immunity.

Alexey Danilov, M.D., PhD: Preclinical and translational research on elucidating novel targets within the ubiquitin-proteasome pathway and mechanism of action and resistance to transcriptional CDKs in B-cell malignancies.

Lara E. Davis, MD: Translational sarcoma research elucidating aspects of the osteosarcoma immune microenvironment and undefined kinase fusions and optimizing CDK4 inhibition to increase sarcoma sensitivity to chemotherapy.

Julia Maxson, PhD: Understanding how genetic alterations cooperate to drive leukemia, and leveraging that information to develop therapeutic strategies.

Gordon Mills, MD, PhD: Translational programs characterizing mechanisms of drug sensitivity and resistance in human tumors with broad array of wet bench and bioinformatics tools.

Amy Moran, PhD: Translational cancer immunotherapy projects evaluating cross talk between sex steroids and immune cell function, role of microbiome, and mechanisms of action of non-conventional of T & NK cell inhibitors.

Ferdinando Pucci, PhD: Humoral immune responses, cell-mediated immunity, and antigen-specific immune reactions to tumor-derived extracellular vesicles impacting malignancy with the goal of developing next generation cancer vaccines.

Rosalie Sears, PhD: Pancreatic cancer research projects focused on tumor heterogeneity, lineage plasticity, epigenetic regulation and mechanisms of therapeutic resistance using omic and image analysis of patient tumors, patient-derived and genetic mouse models.

Josh Walker, M.D., PhD: Tumor cell intrinsic and microenvironmental factors regulating T cell effector dysfunction in cancer, impacting efficacy of novel combinations of chemotherapy, radiotherapy, and immunotherapy in cancer utilizing preclinical models with defined tumor antigens and clinical samples.

Please apply via recruiter’s website.

Favorite